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This study aims to evaluate the effect of an innovative nutritional 
approach combining the consumption of vegetables naturally rich in 
inulin with daily supplementation in native inulin on obese individuals. 
Primary outcome includes the identification of microbiota driven 
improvement of host health 
• Prevalence of Obesity in Europe has reached epidemic 
proportions
• Novel nutritional approach such as inulin-enriched vegetables 
consumption are promising tools to control weight gain and 
related metabolic disorders
Dietary inulin supplementation promotes weight loss
in obese individuals
• Randomized, simple-blind, placebo-controlled parallel study including 150 obese subjects (BMI > 30 kg.m-2 ; 18-65 years, recruited in three university 
hospitals in Belgium).  The preliminary data presented here concern 38 patients (end of recruitment January 2018).
• Subjects must present at least one of the following comorbidities : prediabetes, hypertension, dyslipidemia, liver steatosis.
• Treatment/Placebo consist of a daily consumption of meals (following given recipes) including vegetables naturally rich/poor in inulin. In addition, 
patients receive a daily supplement of 16 g of native Inulin/Maltodextrin (Cosucra).  
• Ethical approval was registered under the number: BE403201422056
• Analysis performed before and after the treatment include : 
 Anthropometric measurements 
 Blood tests 
 Fibroscan (evaluates the level of liver fibrosis)
 CT-scan (Measurement of abdominal fat area)
 Dietary habit evaluation 
 Behavior study 
 Urine, saliva and feces collection 
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• Three months nutritional advices and prebiotic supplementation significantly reduce Body Mass Index in obese individuals. 
• Glucose metabolism, liver fibrosis and visceral fat area tend to improve with the treatment. More patients are needed to confirm these trends.
• Gut microbiota analysis will be performed at the end of the study and will be correlated to health parameters.
These preliminary data's highlight a promising way to prevent obesity and metabolic disorders. To our knowledge, this is the first study to propose 
nutritional advices favoring the consumption of vegetables rich in Inulin. To a larger scale, this approach will lead the patients to manage their 



































Month 1 Month 2
Recruitment
• Included patients : 73 
• Ended the study : 38 






















































































































































































































































































Blood lipid parameters (mg/dl) Change (Final-Initial measurement) Between group
p-value
Placebo Prebiotic
Triglycerides -27,71 ± 13,22 -38,95 ± 38,23 0,26
Total Cholesterol -4,50 ± 7,45 -4,43 ± 4,90 0,99
HDL-Cholesterol 2,143 ± 2,09 1,52 ± 1,00 0,62















































1Data are expressed as mean±SEM ; n=16 in placebo, n=22 in prebiotic ; Statistical analysis were performed on differential values, Mann-Withney non parametric t-test
2
2 Mixed model ANOVA analysis performed
Fasting Glycemia
Placebo Prebiotic
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